Market Value2,600,688,000
Total Holdings93
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CCXI / ChemoCentryx Inc
RPTX / Repare Therapeutics Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
KDMN / Kadmon Holdings Inc
NUVB / Nuvation Bio Inc.
US62857M1053 / MyoKardia, Inc.
KZR / Kezar Life Sciences, Inc.
GMTX / Gemini Therapeutics Inc
BURNING ROCK BIOTECH LTD / SPONSORED ADS (12233L107)
ARYBU / ARYA Sciences Acquisition Corp II
CRSP / CRISPR Therapeutics AG
TBPH / Theravance Biopharma, Inc.
QURE / uniQure N.V.
NERV / Minerva Neurosciences, Inc.
IGMS / IGM Biosciences, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
TWST / Twist Bioscience Corporation
859319303 / Sterling Financial Corp
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
SRNE / Sorrento Therapeutics, Inc. Call
OMER / Omeros Corporation Call
AXSM / Axsome Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
EIGR / Eiger BioPharmaceuticals, Inc.
NKTR / Nektar Therapeutics
HSAQ / Health Sciences Acquisitions Corp 2
ARGX / argenx SE - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
US9266131005 / Viela Bio, Inc.
INSM / Insmed Incorporated
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
TCRR / Tcr2 Therapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A
TRIL / Trillium Therapeutics Inc
FMTX / Forma Therapeutics Holdings Inc
AKRO / Akero Therapeutics, Inc.
QTNT / Quotient Ltd
INSP / Inspire Medical Systems, Inc.
GOSS / Gossamer Bio, Inc.
ARNA / Arena Pharmaceuticals Inc
US74257L1089 / Principia Biopharma Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
DCPH / Deciphera Pharmaceuticals, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
DTIL / Precision BioSciences, Inc.
/ Therapeutics Acquisition Corp. Class A
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
OTLK / Outlook Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
/ Vesper Healthcare Acquisition Corp. Unit
ALBO / Albireo Pharma Inc
CCXI / ChemoCentryx Inc Call
NXTC / NextCure, Inc.
FIXX / Homology Medicines, Inc.
CRDF / Cardiff Oncology, Inc.
MYOV / Myovant Sciences Ltd
SPY / SPDR S&P 500 ETF Put
FATE / Fate Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
OTIC / Otonomy Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
ITOS / iTeos Therapeutics, Inc.
AVRO / AVROBIO, Inc.
SRNE / Sorrento Therapeutics, Inc.
AGEN / Agenus Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ALLK / Allakos Inc.
ANAB / AnaptysBio, Inc.
HARP / Harpoon Therapeutics, Inc.
AVEO / AVEO Pharmaceuticals Inc
MRUS / Merus N.V.
CABA / Cabaletta Bio, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
BCEL / Atreca, Inc.
MORF / Morphic Holding, Inc.
XLRN / Acceleron Pharma Inc
RVMD / Revolution Medicines, Inc.
IMVT / Immunovant, Inc.
OMER / Omeros Corporation
MRTX / Mirati Therapeutics, Inc.
AKUS / Akouos Inc
BPMC / Blueprint Medicines Corporation
RCKT / Rocket Pharmaceuticals, Inc.
XFOR / X4 Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
PLRX / Pliant Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
YMAB / Y-mAbs Therapeutics, Inc.
AXNX / Axonics, Inc.
TPTX / Turning Point Therapeutics Inc
BHVN / Biohaven Ltd.
STOK / Stoke Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
BEAM / Beam Therapeutics Inc.